CVS Health (CVS) PT Raised to $120 at BMO Capital, Following Earnings

February 9, 2022 3:18 PM EST Send to a Friend
BMO Capital analyst Matt Borsch raised the price target on CVS Health (NYSE: CVS) to $120.00 (from $108.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login